ACTG 336--STUDY OF NITAZOXANIDE (NTZ) FOR AIDS CRYPTOSPORIDIOSIS

ACTG 336--硝唑尼特 (NTZ) 治疗艾滋病隐孢子虫病的研究

• 批准号: 6282282
• 负责人: Juan J. L. Lertora
• 金额: $ 1.97万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1999-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6282282
• 关键词: AIDS therapy; HIV infections; antiprotozoal agents; clinical research; cryptosporidiosis; drug screening /evaluation; human subject; human therapy evaluation; microorganism disease chemotherapy; opportunistic infections

The purpose of this study is to determine whether nitazoxanide (an investigational drug) is safe and effective for treating persons with cryptosporidiosis and HIV infection. Cryptosporidiosis is a parasite that infects the intestines of people; it can be a significant problem for persons with HIV infection. In previous studies, nitazoxanide was shown to reduce the number of bowel movements in persons with cryptosporidiosis, but more information is needed.

本研究的目的是确定是否硝唑尼特（一种 研究药物）安全有效地治疗 隐孢子虫病和HIV感染。隐孢子虫病是一种寄生虫， 感染人的肠道;这可能是一个重大的问题， 艾滋病毒感染者。在以前的研究中， 减少排便次数 隐孢子虫病，但需要更多的信息。